Notice for hydroxycarbamide (Norgine Pty Ltd)
Active ingredients
hydroxycarbamide
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
film-coated tablet
Indication
Treatment of sickle cell disease
Therapeutic area
Haematology